| Literature DB >> 31695730 |
Tamaki Matsumoto1, Miho Egawa2, Tetsuya Kimura3, Tatsuya Hayashi4.
Abstract
BACKGROUND: A majority of women from all cultures and socioeconomic levels experience myriad symptoms known as premenstrual syndrome during the days prior to menstruation. The present study investigated commonly reported symptoms in the premenstrual phase among college students. The authors further scrutinized potential factors, including subjective perceptions of health, which may be related to the premenstrual-symptom constellation.Entities:
Keywords: College students; Menstrual distress questionnaire; Premenstrual syndrome; Self-rating stress; Subjective health
Year: 2019 PMID: 31695730 PMCID: PMC6822352 DOI: 10.1186/s13030-019-0167-y
Source DB: PubMed Journal: Biopsychosoc Med ISSN: 1751-0759
Background characteristics of the participants (N = 200)
| Variables | |
|---|---|
| Age (yrs) | 19.8 ± 1.0 |
| Height (cm) | 158.5 ± 5.3 |
| Weight (kg) | 51.4 ± 6.0 |
| Body Mass Index (kg/m2) | 20.5 ± 2.1 |
| Menstrual cycle (days) | 30.0 ± 4.7 |
| Sleeping durations (time) | 6.7 ± 1.1 |
| Breakfast eating habits, no. (%) | 150 (75.0) |
| Regular exercise habits, no. (%) | 55 (27.5) |
Values given as means ± standard deviation
Prevalence rates of premenstrual symptoms (N=200)
| Severity | |||||||
|---|---|---|---|---|---|---|---|
| Factors | Symptoms | No experience | Very mild | Mild | Moderate | Severe | Extremely severe |
| Pain | *Muscle Stiffness | 92 (46.0) | 38 (19.0) | 30 (15.0) | 22 (11.0) | 16 (8.0) | 2 (1.0) |
| *5General aches and pains | 53 (26.5) | 31 (15.5) | 41 (20.5) | 43 (21.5) | 25 (12.5) | 7 (3.5) | |
| Headache | 112 (56.0) | 39 (19.5) | 24 (12.0) | 16 (8.0) | 7 (3.5) | 2 (1.0) | |
| *7Backache | 65 (32.5) | 40 (20.0) | 35 (17.5) | 37 (18.5) | 16 (8.0) | 7 (3.5) | |
| *3Fatigue | 37 (18.5) | 47 (23.5) | 46 (23.0) | 43 (21.5) | 24 (12.0) | 3 (1.5) | |
| Cramps | 196 (98.0) | 3 (1.5) | 0 (0) | 1 (0.5) | 0 (0) | 0 (0) | |
| Concentration | Insomnia | 140 (70.0) | 27 (13.5) | 19 (9.5) | 7 (3.5) | 6 (3.0) | 1 (0.5) |
| Forgetfulness | 141 (70.5) | 32 (16.0) | 18 (9.0) | 6 (3.0) | 3 (1.5) | 0 (0) | |
| Confusion | 139 (69.5) | 24 (12.0) | 23 (11.5) | 8 (4.0) | 6 (3.0) | 0 (0) | |
| Lowered judgment | 105 (52.5) | 37 (18.5) | 31 (15.5) | 17 (8.5) | 9 (4.5) | 1 (0.5) | |
| *Difficulty concentrating | 91 (45.5) | 39 (19.5) | 35 (17.5) | 19 (9.5) | 15 (7.5) | 1 (0.5) | |
| *Distractible | 94 (47.0) | 43 (21.5) | 30 (15.0) | 20 (10.0) | 11 (5.5) | 2 (1.0) | |
| Accidents | 178 (89.0) | 12 (6.0) | 6 (3.0) | 2 (1.0) | 1 (0.5) | 1 (0.5) | |
| Lowered motor coordination | 138 (69.0) | 31 (15.5) | 16 (8.0) | 9 (4.5) | 5 (2.5) | 1 (0.5) | |
| Behavioral change | *6Lowered school or work performance | 53 (26.5) | 56 (28.0) | 41 (20.5) | 32 (16.0) | 15 (7.5) | 3 (1.5) |
| *Take naps; stay in bed | 95 (47.5) | 30 (15.0) | 28 (14.0) | 23 (11.5) | 19 (9.5) | 5 (2.5) | |
| *Stay at home | 100 (50.0) | 41 (20.5) | 28 (14.0) | 16 (8.0) | 11 (5.5) | 4 (2.0) | |
| Avoid social activities | 113 (56.5) | 38 (19.0) | 25 (12.5) | 11 (5.5) | 11 (5.5) | 2 (1.0) | |
| *Decreased efficiency | 92 (46.0) | 46 (23.0) | 33 (16.5) | 20 (10.0) | 9 (4.5) | 0 (0) | |
| Autonomic reactions | Dizziness, faintness | 139 (69.5) | 27 (13.5) | 22 (11.0) | 6 (3.0) | 5 (2.5) | 1 (0.5) |
| Cold sweats | 159 (79.5) | 20 (10.0) | 11 (5.5) | 6 (3.0) | 3 (1.5) | 1 (0.5) | |
| Nausea, vomiting | 146 (73.0) | 24 (12.0) | 20 (10.0) | 4 (2.0) | 3 (1.5) | 3 (1.5) | |
| Hot flashes | 176 (88.0) | 13 (6.5) | 7 (3.5) | 3 (1.5) | 0 (0) | 1 (0.5) | |
| Water retention | *9Weight gain | 69 (34.5) | 38 (19.0) | 43 (21.5) | 35 (17.5) | 12 (6.0) | 3 (1.5) |
| *1Skin disorders | 26 (13.0) | 34 (17.0) | 50 (25.0) | 41 (20.5) | 38 (19.0) | 11 (5.5) | |
| *8Painful breasts | 68 (34.0) | 30 (15.0) | 38 (19.0) | 35 (17.5) | 23 (11.5) | 6 (3.0) | |
| *10Swelling | 77 (38.5) | 41 (20.5) | 45 (22.5) | 17 (8.5) | 14 (7.0) | 6 (3.0) | |
| Negative affect | Crying | 122 (61.0) | 27 (13.5) | 16 (8.0) | 18 (9.0) | 14 (7.0) | 3 (1.5) |
| Loneliness | 117 (58.5) | 27 (13.5) | 22 (11.0) | 13 (6.5) | 20 (10.0) | 1 (0.5) | |
| *Anxiety | 90 (45.0) | 38 (19.0) | 26 (13.0) | 22 (11.0) | 22 (11.0) | 2 (1.0) | |
| *Restlessness | 78 (39.0) | 48 (24.0) | 33 (16.5) | 24 (12.0) | 17 (8.5) | 0 (0) | |
| *2Irritability | 34 (17.0) | 34 (17.0) | 52 (26.0) | 39 (19.5) | 33 (16.5) | 8 (4.0) | |
| *4Mood swings | 45 (22.5) | 34 (17.0) | 49 (24.5) | 32 (16.0) | 30 (15.0) | 10 (5.0) | |
| *Depression | 100 (50.0) | 28 (14.0) | 26 (13.0) | 24 (12.0) | 21 (10.5) | 1 (0.5) | |
| Tension | 142 (71.0) | 31 (15.5) | 12 (6.0) | 9 (4.5) | 5 (2.5) | 1 (0.5) | |
| Arousal | Affectionate | 143 (71.5) | 21 (10.5) | 23 (11.5) | 10 (5.0) | 3 (1.5) | 0 (0) |
| Orderliness | 146 (73.0) | 27 (13.5) | 13 (6.5) | 6 (3.0) | 4 (2.0) | 4 (2.0) | |
| Excitement | 147 (73.5) | 28 (14.0) | 15 (7.5) | 5 (2.5) | 5 (2.5) | 0 (0) | |
| Feeling of well-being | 168 (84.0) | 17 (8.5) | 11 (5.5) | 3 (1.5) | 1 (0.5) | 0 (0) | |
| Bursts of energy, activity | 167 (83.5) | 17 (8.5) | 8 (4.0) | 6 (3.0) | 2 (1.0) | 0 (0) | |
| Control | Feeling of suffocation | 168 (84.0) | 17 (8.5) | 9 (4.5) | 3 (1.5) | 3 (1.5) | 0 (0) |
| Chest pains | 155 (77.5) | 25 (12.5) | 12 (6.0) | 6 (3.0) | 2 (1.0) | 0 (0) | |
| Ringing in the ears | 180 (90.0) | 11 (5.5) | 7 (3.5) | 1 (0.5) | 1 (0.5) | 0 (0) | |
| Heart pounding | 172 (86.0) | 13 (6.5) | 9 (4.5) | 6 (3.0) | 0 (0) | 0 (0) | |
| Numbness, tingling | 190 (95.0) | 5 (2.5) | 1 (0.5) | 2 (1.0) | 2 (1.0) | 0 (0) | |
| Blind spots, fuzzy vision | 166 (83.0) | 17 (8.5) | 12 (6.0) | 3 (1.5) | 1 (0.5) | 1 (0.5) | |
Values given as numbers (percentage)
*Symptoms experienced by more than half of the participants
*1-10Ten symptoms most frequently experienced by the participants
Participants experiencing severe to extremely severe symptoms
| Severe to extremely severe symptoms | Subjects |
|---|---|
| None | 78 (39.0) |
| 1–5 symptoms | 79 (39.5) |
| 6–10 symptoms | 27 (13.5) |
| 11–20 symptoms | 16 (8.0) |
Values are given as numbers (percentage)
Results of stepwise multiple regression analysis: Independent variables influencing MDQ total scores
| Independent variables | B | 95%CI |
| |
|---|---|---|---|---|
| Subjective health | 19.3 | 9.92–28.7 | 0.28 | < 0.001** |
| Self-rating stress | 11.3 | 2.95–19.6 | 0.18 | 0.008** |
B: un-standardized partial regression coefficients; β: standard partial regression coefficient; CI Confidence interval
ANOVA F = 14.7 (2, 197), P < 0.001
R2 = 0.13
**P < 0.01
Fig. 1Comparison of the MDQ total scores among four groups categorized by subjective perception of health and stress
Effects of subjective perception of health and stress on MDQ subscores
| Healthy | Unhealthy | ANOVA | |||
|---|---|---|---|---|---|
| Non-stressful | Stressful | Non-stressful | Stressful | ||
| Pain | 12.7 ± 4.9 | 13.6 ± 3.4 | 14.1 ± 4.8 | 17.4 ± 4.9 | Health effect: |
| Stress effect: | |||||
| Interaction: | |||||
| Concentration | 12.0 ± 5.5 | 14.8 ± 6.7 | 15.8 ± 7.5 | 18.5 ± 6.0 | Health effect: |
| Stress effect: | |||||
| Interaction: | |||||
| Behavioral change | 10.0 ± 5.1 | 10.7 ± 4.7 | 12.3 ± 6.8 | 14.3 ± 6.3 | Health effect: |
| Stress effect: | |||||
| Interaction: | |||||
| Autonomic reactions | 5.2 ± 2.0 | 5.6 ± 2.7 | 7.3 ± 4.1 | 6.9 ± 3.1 | Health effect: |
| Stress effect: | |||||
| Interaction: | |||||
| Water retention | 10.3 ± 4.2 | 11.2 ± 4.0 | 12.4 ± 4.7 | 11.5 ± 3.9 | Health effect: |
| Stress effect: | |||||
| Interaction: | |||||
| Negative affect | 16.2 ± 8.0 | 20.8 ± 9.5 | 20.6 ± 9.6 | 24.5 ± 9.5 | Health effect: |
| Stress effect: | |||||
| Interaction: | |||||
| Arousal | 6.6 ± 3.1 | 7.3 ± 3.2 | 8.3 ± 4.0 | 8.6 ± 4.0 | Health effect: |
| Stress effect: | |||||
| Interaction: | |||||
| Control | 7.0 ± 2.0 | 7.5 ± 2.2 | 8.9 ± 3.4 | 8.7 ± 3.5 | Health effect: |
| Stress effect: | |||||
| Interaction: | |||||
Vales given as means ± standard deviation
Statistical significance, **p < 0.01, *p < 0.05
Comparison of ‘healthy & non-stressed’ and ‘unhealthy & stressed’ groups
| Healthy & Non-stressed | Unhealthy & Stressed | ||
|---|---|---|---|
| Background and lifestyle risk factors, no. (%) | |||
| Age (yrs) | 19.7 ± 0.9 | 19.9 ± 0.8 | 0.402 |
| Body Mass Index (kg/m2) | 20.4 ± 2.1 | 19.5 ± 2.0 | 0.178 |
| Menstrual cycle (days) | 30.0 ± 3.8 | 29.0 ± 3.5 | 0.265 |
| Sleeping durations (time) | 6.7 ± 1.0 | 6.6 ± 1.6 | 0.505 |
| Breakfast eating habits, no. (%) | 91 (74.6) | 10 (52.6) | 0.048* |
| Regular exercise habits, no. (%) | 32 (26.2) | 4 (21.1) | 0.630 |
| Premenstrual symptoms (over severe severity), no. (%) | |||
| General aches and pains | 19 (15.6) | 7 (36.8) | 0.026* |
| Confusion | 0 (0) | 3 (15.8) | 0.002** |
| Lowered school or work performance | 8 (6.6) | 4 (21.1) | 0.035* |
| Decreased efficiency | 1 (0.8) | 3 (15.8) | 0.008** |
| Loneliness | 8 (6.6) | 5 (26.3) | 0.006** |
| Anxiety | 8 (6.6) | 6 (31.6) | 0.001** |
| Restlessness | 7 (5.7) | 6 (31.6) | < 0.001** |
| Mood swings | 17 (13.9) | 8 (42.1) | 0.003** |
| Depression | 10 (8.2) | 5 (26.3) | 0.017* |
Vales given as means ± standard deviation
Statistical significance, **p < 0.01, *p < 0.05